European Journal of Cancer
Volume 45, Issue 1 , Pages 8-11 , January 2009

Managing cancer-related anaemia in congruence with the EORTC guidelines is an independent predictor of haemoglobin outcome: Initial evidence from the RESPOND study

  • Matti Aapro

      Affiliations

    • Institut Multidisciplinaire d’Oncologie, Clinique de Genolier, 1 Route du Muids, CH-1272 Genolier, Switzerland
    • ,
  • Joanna Van Erps

      Affiliations

    • Afdeling Oncologie en Hematologie, Algemeen Stedelijk Ziekenhuis Aalst, Merestraat 80, B-9300 Aalst, Belgium
    • ,
  • Karen MacDonald

      Affiliations

    • Matrix45, 620 Frays Ridge Road, Earlysville, VA 22936, USA
    • ,
  • Pierre Soubeyran

      Affiliations

    • Institut Bergonié, 229 cours de l’Argonne, F-33076 Bordeaux, France
    • Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, F-33076 Bordeaux, France
    • ,
  • Michael Muenzberg

      Affiliations

    • F. Hoffmann-La Roche AG, Grenzacherstrasse, Bau 74, CH-4070 Basel, Switzerland
    • ,
  • Matthew Turner

      Affiliations

    • F. Hoffmann-La Roche AG, Grenzacherstrasse, Bau 74, CH-4070 Basel, Switzerland
    • ,
  • Hans Warrinnier

      Affiliations

    • Roche, Dantestraat 75, B-1070 Brussel, Belgium
    • ,
  • Tara Albrecht

      Affiliations

    • Matrix45, 620 Frays Ridge Road, Earlysville, VA 22936, USA
    • School of Nursing, University of Virginia, 202 15th Street SW, Charlottesville, VA 22903, USA
    • ,
  • Ivo Abraham

      Affiliations

    • Matrix45, 620 Frays Ridge Road, Earlysville, VA 22936, USA
    • College of Nursing and Center for Health Outcomes and Pharmacoeconomic Research, Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, 1305 N. Martin Road, Tucson, AZ 85721, USA
    • Corresponding Author InformationCorresponding author: Address: Matrix45, 620 Frays Ridge Road, Earlysville, VA 22936, USA. Tel.: +1 303 997 2697; fax: +1 978 945 8374.

Received 22 June 2008 ,Revised 5 September 2008 ,Accepted 30 September 2008.

References 

  1. Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer. 2004;40:2201–2216
  2. Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer. 2007;43:258–270
  3. Aapro M, Van Erps J, MacDonald K, et al. Promoting evidence-based management of anemia in cancer patients: background, development, and scientific validation of RESPOND, a web-based clinical guidance system based on the EORTC guidelines. Crit Rev Oncol Hematol. 2008;65:32–42
  4. Aapro M, Abraham I, MacDonald K, et al. Intraclass correlation metrics for the accuracy of algorithmic definitions in a computerized decision support system for supportive cancer care. Support Care Cancer. 2007;15:1325–1329
  5. Van Erps J, Aapro M, MacDonald K, et al. Promoting evidence-based management of anemia in cancer patients: concurrent, and discriminant validity of RESPOND, a web-based clinical guidance system based on the EORTC guidelines [submitted for publication].
  6. Aapro M, Birgegard G, Bokemeyer C, et al. Erythropoietins should be used according to guidelines. Lancet Oncol. 2008;9:412–413

PII: S0959-8049(08)00784-3

doi: 10.1016/j.ejca.2008.09.036

European Journal of Cancer
Volume 45, Issue 1 , Pages 8-11 , January 2009

Article Tools